Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  NuPathe Inc    PATH   US67059M1009

NUPATHE INC (PATH)

3
 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancials 
Company
NuPathe Inc. is a biopharmaceutical company focused on the development and commercialization of branded therapeutics for diseases of the central nervous system, including neurological and psychiatric disorders.Its primary product, Zecuity (sumatriptan iontophoretic transdermal) for the acute... 
Sector
Pharmaceuticals
Calendar
03/24Earnings Release
More about the company
Chart NUPATHE INC
Duration : Period :
NuPathe Inc Technical Analysis Chart | PATH | US67059M1009 | 4-Traders
Full-screen chart
Latest news on NUPATHE INC
2014 NUPATHE INC : Teva Completes Tender Offer for NuPathe Inc. Shares
2014 TEVA PHARMACEUTICAL INDUSTRIES LIMIT : Teva Finalizes Tender Offer for NuPath Sh..
2014 NUPATHE INC : NUPATHE INC. FILES (8-K) Disclosing Termination of a Material Defi..
2014 NUPATHE INC : Teva Expands CNS Specialty Business with Acquisition of NuPathe
2014 Analysis - Replay of energetic deal-making seen for drugmakers in 2014
2014DJU.S. HOT STOCKS : Hot Stocks to Watch
2014 NUPATHE INC : Endo Merger Agreement with NuPathe Terminated
2014 NuPathe Terminates Agreement With Endo and Enters Into Agreement to Be Acquir..
More news
Sector news Pharmaceuticals - NEC
08:46a MALLINCKRODT : Technical Commentary on Pharma Stocks -- Merck, AbbVie, Bristol-M..
08:44a Drugmaker AbbVie beats estimates as Humira sales rise
08:43aDJAbbVie Tops Expectations, Gives First Look at Viekira Sales
Plus d'actualités du secteur Pharmaceuticals - NEC


Comments 
Advertisement
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF